Use of PPAR-delta agonists in the treatment of disease Grant US-11931365-B2 United States of America 19 Mar 2024
Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I… Grant US-11096946-B2 United States of America 24 Aug 2021
Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I… Grant US-10456406-B2 United States of America 29 Oct 2019